282 related articles for article (PubMed ID: 22999754)
1. Anatomic features and retrograde transvenous obliteration of duodenal varices associated with mesocaval collateral pathway.
Okahara M; Kiyosue H; Ueda S; Kashiwagi J; Tanoue S; Hongo N; Mori H
J Vasc Interv Radiol; 2012 Oct; 23(10):1339-46. PubMed ID: 22999754
[TBL] [Abstract][Full Text] [Related]
2. Development of a new coaxial balloon catheter system for balloon-occluded retrograde transvenous obliteration (B-RTO).
Tanoue S; Kiyosue H; Matsumoto S; Hori Y; Okahara M; Kashiwagi J; Mori H
Cardiovasc Intervent Radiol; 2006; 29(6):991-6. PubMed ID: 16736100
[TBL] [Abstract][Full Text] [Related]
3. Endovascular obliteration of bleeding duodenal varices in patients with liver cirrhosis.
Zamora CA; Sugimoto K; Tsurusaki M; Izaki K; Fukuda T; Matsumoto S; Kuwata Y; Kawasaki R; Taniguchi T; Hirota S; Sugimura K
Eur Radiol; 2006 Jan; 16(1):73-9. PubMed ID: 15856238
[TBL] [Abstract][Full Text] [Related]
4. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals.
Koito K; Namieno T; Nagakawa T; Morita K
AJR Am J Roentgenol; 1996 Nov; 167(5):1317-20. PubMed ID: 8911204
[TBL] [Abstract][Full Text] [Related]
5. Successful balloon-occluded retrograde transvenous obliteration for bleeding duodenal varices using cyanoacrylate.
Hashimoto R; Sofue K; Takeuchi Y; Shibamoto K; Arai Y
World J Gastroenterol; 2013 Feb; 19(6):951-4. PubMed ID: 23429766
[TBL] [Abstract][Full Text] [Related]
6. Bleeding duodenal varices successfully treated with balloon-occluded retrograde transvenous obliteration (B-RTO) assisted by CT during arterial portography.
Tsurusaki M; Sugimoto K; Matsumoto S; Izaki K; Fukuda T; Akasaka Y; Fujii M; Hirota S; Sugimura K
Cardiovasc Intervent Radiol; 2006; 29(6):1148-51. PubMed ID: 15999240
[TBL] [Abstract][Full Text] [Related]
7. Stomal varices: management with decompression tips and transvenous obliteration or sclerosis.
Saad WE; Saad NE; Koizumi J
Tech Vasc Interv Radiol; 2013 Jun; 16(2):176-84. PubMed ID: 23830674
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of 154 patients receiving balloon-occluded retrograde transvenous obliteration for gastric fundal varices.
Imai Y; Nakazawa M; Ando S; Sugawara K; Mochida S
J Gastroenterol Hepatol; 2016 Nov; 31(11):1844-1850. PubMed ID: 27003222
[TBL] [Abstract][Full Text] [Related]
9. Successful management of duodenal varices by balloon-occluded retrograde transvenous obliteration.
Hotta M; Yoshida H; Mamada Y; Taniai N; Bando K; Mizuguchi Y; Kakinuma D; Kanda T; Watanabe K; Tajiri T
J Nippon Med Sch; 2008 Feb; 75(1):36-40. PubMed ID: 18360078
[TBL] [Abstract][Full Text] [Related]
10. Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: Polidocanol Foam Versus Liquid Ethanolamine Oleate.
Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y
AJR Am J Roentgenol; 2015 Sep; 205(3):659-66. PubMed ID: 26295655
[TBL] [Abstract][Full Text] [Related]
11. Balloon-occluded retrograde transvenous obliteration of gastric varices: use of CT-guided foam sclerotherapy to optimize technique.
Koizumi J; Hashimoto T; Myojin K; Itou C; Kagawa T; Nishibe T; Janne d'Othée B
AJR Am J Roentgenol; 2012 Jul; 199(1):200-7. PubMed ID: 22733913
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) Using Ethanolamine Oleate (EO), BRTO Using Sodium Tetradecyl Sulfate (STS) Foam and Vascular Plug-Assisted Retrograde Transvenous Obliteration (PARTO).
Kim YH; Kim YH; Kim CS; Kang UR; Kim SH; Kim JH
Cardiovasc Intervent Radiol; 2016 Jun; 39(6):840-6. PubMed ID: 26757912
[TBL] [Abstract][Full Text] [Related]
13. Balloon-occluded retrograde transvenous obliteration using a microballoon catheter for intractable gastric fundal varices.
Imai Y; Nakazawa M; Ando S; Sugawara K; Hamaoka K; Oka M; Mochida S
J Gastroenterol Hepatol; 2014 Feb; 29(2):365-71. PubMed ID: 23927078
[TBL] [Abstract][Full Text] [Related]
14. Combination of transileocolic vein obliteration and balloon-occluded retrograde transvenous obliteration is effective for ruptured duodenal varices.
Ota K; Okazaki M; Higashihara H; Kokawa H; Shirai Z; Anan A; Kitamura Y; Shijo H
J Gastroenterol; 1999 Dec; 34(6):694-9. PubMed ID: 10588186
[TBL] [Abstract][Full Text] [Related]
15. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients.
Cho SK; Shin SW; Lee IH; Do YS; Choo SW; Park KB; Yoo BC
AJR Am J Roentgenol; 2007 Dec; 189(6):W365-72. PubMed ID: 18029851
[TBL] [Abstract][Full Text] [Related]
16. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage.
Kitamoto M; Imamura M; Kamada K; Aikata H; Kawakami Y; Matsumoto A; Kurihara Y; Kono H; Shirakawa H; Nakanishi T; Ito K; Chayama K
AJR Am J Roentgenol; 2002 May; 178(5):1167-74. PubMed ID: 11959725
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes of Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: A Comparison of Ethanolamine Oleate and Sodium Tetradecyl Sulfate.
Chu HH; Kim M; Kim HC; Lee JH; Jae HJ; Chung JW
Cardiovasc Intervent Radiol; 2018 Apr; 41(4):578-586. PubMed ID: 29264640
[TBL] [Abstract][Full Text] [Related]
18. The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications.
Saad WE; Kitanosono T; Koizumi J; Hirota S
Tech Vasc Interv Radiol; 2013 Jun; 16(2):101-51. PubMed ID: 23830671
[TBL] [Abstract][Full Text] [Related]
19. Infusion of 50% glucose solution before injection of ethanolamine oleate during balloon-occluded retrograde transvenous obliteration.
Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Nishimura T
Australas Radiol; 2007 Aug; 51(4):334-8. PubMed ID: 17635469
[TBL] [Abstract][Full Text] [Related]
20. The role of divided injections of a sclerotic agent over two days in balloon-occluded retrograde transvenous obliteration for large gastric varices.
Yamagami T; Yoshimatsu R; Miura H; Matsumoto T; Hasebe T
Korean J Radiol; 2013; 14(3):439-45. PubMed ID: 23690710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
